Southern_Cross's Portfolio

Here is the latest portfolio

Sr. No Company Sector Capitalisation Allocation % Rationale
1 HDFC ASSET MANAGEMENT COMPANY LIMITED (XNSE:HDFCAMC) Financial Large Cap 11% Financialization theme
2 BSE Limited (XNSE:BSE) Financial Small Cap 11% Financialization theme
3 AVENUE SUPERMARTS LIMITED (XNSE:DMART) Services Large Cap 10% Long-term retail play, debt free
4 HCL TECHNOLOGIES LIMITED (XNSE:HCLTECH) Technology Large Cap 8% Coffee Can
5 LAURUS LABS LIMITED (XNSE:LAURUSLABS) Healthcare Mid Cap 7% Growth
6 DEEPAK NITRITE LIMITED (XNSE:DEEPAKNTR) Chemicals Mid Cap 7% Growth
7 OLECTRA GREENTECH LIMITED (XNSE:OLECTRA) Engineering Small Cap 6% Promising sector for future
8 ABBOTT INDIA LIMITED (XNSE:ABBOTINDIA) Healthcare Mid Cap 5% Coffee Can
9 ASTRAL LIMITED (XNSE:ASTRAL) Chemicals Mid Cap 5% Coffee Can
10 NAZARA TECHNOLOGIES LIMITED (XNSE:NAZARA) Technology Small Cap 5% Promising sector for future
11 TITAN COMPANY LIMITED (XNSE:TITAN) Cons Durable Large Cap 4% Long-term retail play, debt free
12 DR. LAL PATHLABS Limited (XNSE:LALPATHLAB) Healthcare Mid Cap 3% Coffee Can
13 PSP PROJECTS LIMITED (XNSE:PSPPROJECT) Construction Small Cap 3% Asset Light business in construction
14 GATEWAY DISTRIPARKS LTD. (XNSE:GDL) Services Small Cap 3% Promising sector for future
15 PAGE INDUSTRIES LIMITED (XNSE:PAGEIND) Textiles Mid Cap 2% Coffee Can
16 INDIAN ENERGY EXCHANGE LIMITED (XNSE:IEX) Services Mid Cap 2% Growth
17 HDFC BANK LIMITED (XNSE:HDFCBANK) Financial Large Cap 2% Coffee Can
18 AMBIKA COTTON MILLS LIMITED (XBOM:531978) Textiles Small Cap 1% Tracking
19 KOVAI MEDICAL CENTER AND HOSPITAL LIMITED (XBOM:523323) Healthcare Small Cap 1% Tracking
20 LUPIN LIMITED (XNSE:LUPIN) Healthcare Mid Cap 1% Coffee Can
Stocks
Top 5 47%
Top 10 75%
Top 15 90%
Top 20 97%
Market Cap
Large Cap 36%
Mid Cap 33%
Small Cap 31%
Sector Split
Financial 24%
Healthcare 18%
Services 15%
Technology 14%
Chemicals 12%
Engineering 6%
Cons Durable 4%
Textiles 3%
Construction 3%

Investing Objectives –

Return of Capital - :+1:
Beat BSE Sensex in terms of CAGR :+1:
Beat FD returns :+1:
Reach 15% CAGR :+1:
Beat MF(direct) returns (26.8% CAGR so far) :-1: The difference is 1.4 now

Changes –

  • Removed stocks where conviction is less and wherever there is lesser allocation
    o Sold off Zomato, Cupid, Kaveri Seeds, LIC Housing Finance, Muthoot Capital Services, NMDC, Repco, SBI Cards
  • Increased allocation to Titan after Q2 FY22 results
  • Increased allocations in HCL Technologies, Abbott India & HDFC AMC when the market was trading in deep red
  • Sold off Zomato as it is more of a hope story and bought Dr. Lalpath labs during news of Omicron almost at the same price where I sold earlier
  • Increased allocation to Olectra based on the below rationale
    Olectra Greentech - Electric Bus Opportunity

Notes –

  • Understood that selling half of the shares once we the share price doubles is bad idea. In fact, selling decision should be taken based on the stock specific valuation or overall pf allocation for that sector
  • As I removed most of the tail(less allocations) , I deployed more capital into the high conviction ones
  • BSE Limited is more than 4x now
  • Increased allocation to defensives(IT,Pharma) to 31% and New Age(Nazara, Nykaa, Olectra) to 12%. The plan is to increase allocation to New Age businesses to 20% in future.
  • With 90% of allocation in Top 15 stocks, I will have more to do research per stock
  • Got Nykaa IPO allottment :blush:
  • Evaluating whether I am better off by moving equity to PMS or MF rather than direct investing. Looking forward to how I perform during bear market.

Interesting videos

  • Samit Vartak has beautifully explained about how to build a superior portfolio to generate 10x in 10 years
  • Another great learning about portfolio construction by SOIC
  • Very interesting discussion between Rakesh Jhunjhunwala and Akash Prakash from Amansa
5 Likes